![Jeffrey Bailey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Bailey
Directeur/Membre du Conseil chez
AURINIA PHARMACEUTICALS INC.
Fortune : 349 141 $ au 31/05/2026
Profil
Jeffrey Allen Bailey is Director at Madison Vaccines, Inc. since 2017.
Independent Director at Aurinia Pharmaceuticals, Inc. and Director at Aberdeen Investments LLC since 2023.
Independent Trustee at abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund, and abrdn World Healthcare Fund since 2020.
Former Chief Executive Officer & Director at BioDelivery Sciences International, Inc. from 2020 to 2022.
Former Chief Executive Officer & Director at IlluminOss Medical, Inc. from 2018 to 2020.
Former Chairman at Tekla Capital Management LLC from 2020 to 2023.
Former Chairman at Rein Therapeutics, Inc. from 2018 to 2023.
Former Executive Chairman & Chief Executive Officer at Neurovance, Inc. from 2015 to 2017.
Former President, Chief Executive Officer & Director at Lantheus Medical Imaging, Inc. and Lantheus Holdings, Inc. from 2013 to 2015.
Former Director at Biodelivery Systems, Inc. from 2020 to 2022.
Former Chief Operating Officer at Fougera Pharmaceuticals, Inc. from 2011 to 2012.
Former Chief Commercial Officer at KP Pharmaceuticals LLC from 2010 to 2011.
Former President & GM-Northwest Operating Unit at Novartis Pharmaceuticals Corp.
and President & General Manager at Novartis AG from 2008 to 2010.
Former Vice President-Sales at Johnson & Johnson from 1984 to 2004.
Former Independent Director at Landauer, Inc. and Director at ImaginAb, Inc. Former Vice President-Marketing at Mainevest LLC.
Education includes undergraduate degree from Rutgers State University of New Jersey.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 22 775 ( 0,02 % ) | 349 141 $ | 31/05/2026 |
Postes actifs de Jeffrey Bailey
| Sociétés | Poste | Début |
|---|---|---|
| ABRDN WORLD HEALTHCARE FUND | Directeur/Membre du Conseil | 01/01/2020 |
| ABRDN HEALTHCARE INVESTORS | Directeur/Membre du Conseil | 01/01/2020 |
| ABRDN LIFE SCIENCES INVESTORS | Directeur/Membre du Conseil | 01/01/2020 |
| ABRDN HEALTHCARE OPPORTUNITIES FUND | Directeur/Membre du Conseil | 01/01/2020 |
| AURINIA PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 18/08/2023 |
Aberdeen Investments LLC
 Aberdeen Investments LLC Financial ConglomeratesFinance Provides investment services | Directeur/Membre du Conseil | 01/01/2023 |
Madison Vaccines, Inc.
 Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for patients with prostate cancer | Directeur/Membre du Conseil | 27/10/2017 |
Anciens postes connus de Jeffrey Bailey
| Sociétés | Poste | Fin |
|---|---|---|
| REIN THERAPEUTICS INC. | Président | 31/10/2023 |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Président | 01/01/2023 |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Jeffrey Bailey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Landauer, Inc.
 Landauer, Inc. Information Technology ServicesTechnology Services Provides radiation safety technology and compliance solutions | Technology Services |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Lantheus Medical Imaging, Inc.
 Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
IlluminOss Medical, Inc.
 IlluminOss Medical, Inc. Medical SpecialtiesHealth Technology Designs, develops and markets orthopedic fracture repair products | Health Technology |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops treatments for central nervous system disorders | Commercial Services |
abrdn Healthcare Investors
 abrdn Healthcare Investors Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
abrdn Life Sciences Investors
 abrdn Life Sciences Investors Investment Trusts/Mutual FundsMiscellaneous Functions as a closed-end investment fund or Investment trust | Miscellaneous |
abrdn Healthcare Opportunities Fund
 abrdn Healthcare Opportunities Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
abrdn World Healthcare Fund
 abrdn World Healthcare Fund Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Tekla Capital Management LLC
Tekla Capital Management LLC Investment ManagersFinance Tekla primarily focuses on healthcare investing. Their funds invest in public and private growth equities in the healthcare and life sciences industries. | Finance |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Fougera Pharmaceuticals, Inc.
 Fougera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures dermatology pharmaceuticals | Health Technology |
ImaginAb, Inc.
 ImaginAb, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing radiopharmaceutical and imaging agent products | Health Technology |
Mainevest LLC | |
Lantheus Holdings, Inc.
 Lantheus Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures, markets, sells and distributes medical imaging products | Health Technology |
Madison Vaccines, Inc.
Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for patients with prostate cancer | Health Technology |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Aberdeen Investments LLC
Aberdeen Investments LLC Financial ConglomeratesFinance Provides investment services | Finance |
Biodelivery Systems, Inc. |
